Seven glucagon-like peptide-1 receptor agonists and polyagonists for weight loss in patients with obesity or overweight: an updated systematic review and network meta-analysis of randomized controlled trials.
Citations
0
Subjects
Non-Human
Study Context
Meta-analyses statistically combine data from multiple independent studies to increase statistical power and precision. By pooling results, they can detect effects that individual studies may be too small to identify.
What This Study Type Means
- Increased statistical power from combined sample sizes
- Can resolve conflicting results across individual studies
- Quantifies overall effect size with confidence intervals
- Heterogeneity analysis reveals how consistent findings are across studies
Evidence Reliability: Very High — meta-analyses provide the most precise estimate of treatment effects
How to Interpret This Research
Look for the sample size — larger studies produce more reliable results. Single-digit sample sizes warrant caution.
Check whether the study was funded by a pharmaceutical company or conducted independently, as funding sources can influence study design and reporting.
Always consult a qualified healthcare provider before making treatment decisions based on research findings. Published research is not a substitute for personalized medical advice.
Citation
Xie Zeyu, Zheng Guimei, Liang Zhuoru et al.. (2024). Seven glucagon-like peptide-1 receptor agonists and polyagonists for weight loss in patients with obesity or overweight: an updated systematic review and network meta-analysis of randomized controlled trials.. Metabolism: clinical and experimental. https://doi.org/10.1016/j.metabol.2024.156038
Related Papers
Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance.
From Regeneration to Analgesia: The Role of BPC-157 in Tissue Repair and Pain Management.
Carbonless amino acids and a carbonless GHK peptide.
The GHK-Cu delays aging in Caenorhabditis elegans via coordinated regulation of mitochondrial function and activation of DAF-16/SKN-1 pathways.
Glycyl-L-histidyl-L-lysine-Cu2
Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians.
Explore Further
This content is derived from peer-reviewed research for educational purposes only. It does not constitute medical advice. Always consult a qualified healthcare provider before using any peptide-based therapy.